查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1417455

脊椎生物製藥市場報告：2030 年趨勢、預測與競爭分析

Spine Biologic Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

脊椎生物製藥趨勢與預測

到 2030 年，全球脊椎生物製藥市場預計將達到 33 億美元，2024 年至 2030 年複合年成長率為 4.5%。市場的主要驅動力是脊椎畸形盛行率的上升以及人們對微創醫療技術的認知和患者偏好的提高。全球脊椎生物製藥市場的未來充滿希望，醫院和門診手術中心市場充滿機會。

脊椎生物製藥市場洞察

Lucintel 預測，骨移植將在預測期內繼續成為最大的部分，因為它減少了疾病傳播的機會。

在這個市場中，醫院預計將經歷最高的成長。這是因為醫院擁有豐富的醫療資源，包括專業部門和多學科團隊，可以提供頻譜的脊椎護理服務。

由於其強大的醫療保健系統、主要行業領導者的存在以及該地區對微創手術的認知和願望不斷增強，預計北美在預測期內將出現最高的成長。

常問問題

Q1.市場規模有多大？

A1. 到 2030 年，全球脊椎生物製藥市場預計將達到 33 億美元。

Q2.市場成長預測如何？

A2. 2024年至2030年，全球脊椎生物製藥市場預計將以4.5%的複合年成長率成長。

Q3.影響市場成長的主要促進因素有哪些？

A3. 該市場的主要驅動力是脊椎畸形盛行率的上升以及人們對微創醫療技術的認知和患者偏好的提高。

Q4.市場的主要細分市場是什麼？

A4. 脊椎生物製藥市場前景廣闊，醫院和門診手術中心市場充滿機會。

Q5.市場上主要企業有哪些？

A5. 生產脊椎生物製藥的主要企業如下。

  • Zimmer Biomet Holdings
  • Johnson and Johnson
  • Orthofix Medical
  • Stryker
  • Arthrex
  • Medtronic
  • K2M
  • Exactech
  • Wright Medical Technology
  • Nuvasive

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預測，骨移植在預測期內仍將是最大的部分，因為它減少了疾病傳播的機會。

Q7. 未來五年預計哪個地區將成為最大的市場？

A7. 由於其強大的醫療保健系統、主要行業領導者的存在以及該地區對微創手術的認知和願望不斷增強，預計北美在預測期內將呈現最高的成長。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球脊椎生物製藥市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球脊椎生技藥品市場趨勢（2018-2023）與預測（2024-2030）
  • 全球脊椎生物製藥市場，依產品
    • 骨移植
    • 骨移植替代物
    • 富含血小板的血漿
    • 骨髓抽吸治療
    • 其他
  • 全球脊椎生物製藥市場（按材料）
    • 前路頸切除術融合術
    • 後路椎間融合
    • 椎間椎間融合融合術
    • 前路腰椎椎間融合
    • 側方腰椎身體固定
  • 全球脊椎生技藥品市場（依最終用途產業）
    • 醫院
    • 門診外科
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球脊椎生技藥品市場區域分佈
  • 北美脊椎生技藥品市場
  • 歐洲脊椎生技藥品市場
  • 亞太地區脊椎生技藥品市場
  • 其他地區脊椎生技藥品市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球脊椎生物製藥市場成長機會（按產品）
    • 全球脊椎生物製藥市場成長機會（按材料）
    • 最終用途產業的全球脊椎生技藥品市場成長機會
    • 按地區分類的全球脊椎生物製藥市場成長機會
  • 全球脊椎生物製藥市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 全球脊椎生技藥品市場的產能擴張
    • 全球脊椎生物製藥市場的合併、收購和合資企業
    • 認證和許可

第7章主要企業概況

  • Zimmer Biomet Holdings
  • Johnson and Johnson
  • Orthofix Medical
  • Stryker
  • Arthrex
  • Medtronic
  • K2M
  • Exactech
  • Wright Medical Technology
  • Nuvasive
簡介目錄

Spine Biologic Trends and Forecast

The future of the global spine biologic market looks promising with opportunities in the hospitals and ambulatory surgical centres markets. The global spine biologic market is expected to reach an estimated $3.3 billion by 2030 with a CAGR of 4.5% from 2024 to 2030. The major drivers for this market are rising incidence of spinal deformities and growing recognition and patient inclination toward less invasive medical techniques.

A more than 150-page report is developed to help in your business decisions.

Spine Biologic by Segment

The study includes a forecast for the global spine biologic by product, material, end use industry, and region.

Spine Biologic Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Bone Grafts
  • Bone Graft Substitutes
  • Platelet-Rich Plasma
  • Bone Marrow Aspirate Therapy
  • Others

Spine Biologic Market by Material [Shipment Analysis by Value from 2018 to 2030]:

  • Anterior Cervical Discectomy & Fusion
  • Posterior Lumbar Interbody Fusion
  • Transforaminal Lumbar Interbody Fusion
  • Anterior Lumbar Interbody Fusion
  • Lateral Lumbar Interbody Fusion

Spine Biologic Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital
  • Ambulatory Surgical
  • Others

Spine Biologic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Spine Biologic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies spine biologic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the spine biologic companies profiled in this report include-

  • Zimmer Biomet Holdings
  • Johnson and Johnson
  • Orthofix Medical
  • Stryker
  • Arthrex
  • Medtronic
  • K2M
  • Exactech
  • Wright Medical Technology
  • Nuvasive

Spine Biologic Market Insights

Lucintel forecasts that bone graft will remain the largest segment over the forecast period due to it lowers the chances of disease transmission.

Within this market, hospital is expected to witness the highest growth due to they are furnished with extensive healthcare resources, encompassing specialized divisions and interdisciplinary teams capable of delivering a complete spectrum of spinal care services.

North America is expected to witness highest growth over the forecast period due to robust healthcare system, the presence of key industry leaders, and a growing awareness and desire for minimally invasive procedures in this region.

Features of the Global Spine Biologic Market

Market Size Estimates: Spine biologic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Spine biologic market size by product, material, end use industry, and region in terms of value ($B).

Regional Analysis: Spine biologic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, material, end use industry, and regions for the spine biologic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the spine biologic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the spine biologic market size?

Answer: The global spine biologic market is expected to reach an estimated $3.3 billion by 2030.

Q2. What is the growth forecast for spine biologic market?

Answer: The global spine biologic market is expected to grow with a CAGR of 4.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the spine biologic market?

Answer: The major drivers for this market are rising incidence of spinal deformities and growing recognition and patient inclination toward less invasive medical techniques.

Q4. What are the major segments for spine biologic market?

Answer: The future of the spine biologic market looks promising with opportunities in the hospitals and ambulatory surgical centres markets.

Q5. Who are the key spine biologic market companies?

Answer: Some of the key spine biologic companies are as follows.

  • Zimmer Biomet Holdings
  • Johnson and Johnson
  • Orthofix Medical
  • Stryker
  • Arthrex
  • Medtronic
  • K2M
  • Exactech
  • Wright Medical Technology
  • Nuvasive

Q6. Which spine biologic market segment will be the largest in future?

Answer: Lucintel forecasts that bone graft will remain the largest segment over the forecast period due to it lowers the chances of disease transmission.

Q7. In spine biologic market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to robust healthcare system, the presence of key industry leaders, and a growing awareness and desire for minimally invasive procedures in this region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the spine biologic market by product (bone grafts, bone graft substitutes, platelet-rich plasma, bone marrow aspirate therapy, and others), material (anterior cervical discectomy & fusion, posterior lumbar interbody fusion, transforaminal lumbar interbody fusion, anterior lumbar interbody fusion, and lateral lumbar interbody fusion), end use industry (hospital, ambulatory surgical, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Spine Biologic Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Spine Biologic Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Spine Biologic Market by Product
    • 3.3.1: Bone Grafts
    • 3.3.2: Bone Graft Substitutes
    • 3.3.3: Platelet-Rich Plasma
    • 3.3.4: Bone Marrow Aspirate Therapy
    • 3.3.5: Others
  • 3.4: Global Spine Biologic Market by Material
    • 3.4.1: Anterior Cervical Discectomy & Fusion
    • 3.4.2: Posterior Lumbar Interbody Fusion
    • 3.4.3: Transforaminal Lumbar Interbody Fusion
    • 3.4.4: Anterior Lumbar Interbody Fusion
    • 3.4.5: Lateral Lumbar Interbody Fusion
  • 3.5: Global Spine Biologic Market by End Use Industry
    • 3.5.1: Hospital
    • 3.5.2: Ambulatory Surgical
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Spine Biologic Market by Region
  • 4.2: North American Spine Biologic Market
    • 4.2.2: North American Spine Biologic Market by End Use Industry: Hospital, Ambulatory Surgical, and Others
  • 4.3: European Spine Biologic Market
    • 4.3.1: European Spine Biologic Market by Product: Bone Grafts, Bone Graft Substitutes, Platelet-Rich Plasma, Bone Marrow Aspirate Therapy, and Others
    • 4.3.2: European Spine Biologic Market by End Use Industry: Hospital, Ambulatory Surgical, and Others
  • 4.4: APAC Spine Biologic Market
    • 4.4.1: APAC Spine Biologic Market by Product: Bone Grafts, Bone Graft Substitutes, Platelet-Rich Plasma, Bone Marrow Aspirate Therapy, and Others
    • 4.4.2: APAC Spine Biologic Market by End Use Industry: Hospital, Ambulatory Surgical, and Others
  • 4.5: ROW Spine Biologic Market
    • 4.5.1: ROW Spine Biologic Market by Product: Bone Grafts, Bone Graft Substitutes, Platelet-Rich Plasma, Bone Marrow Aspirate Therapy, and Others
    • 4.5.2: ROW Spine Biologic Market by End Use Industry: Hospital, Ambulatory Surgical, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Spine Biologic Market by Product
    • 6.1.2: Growth Opportunities for the Global Spine Biologic Market by Material
    • 6.1.3: Growth Opportunities for the Global Spine Biologic Market by End Use Industry
    • 6.1.4: Growth Opportunities for the Global Spine Biologic Market by Region
  • 6.2: Emerging Trends in the Global Spine Biologic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Spine Biologic Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Spine Biologic Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Zimmer Biomet Holdings
  • 7.2: Johnson and Johnson
  • 7.3: Orthofix Medical
  • 7.4: Stryker
  • 7.5: Arthrex
  • 7.6: Medtronic
  • 7.7: K2M
  • 7.8: Exactech
  • 7.9: Wright Medical Technology
  • 7.10: Nuvasive